Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
08/01/2026 22:28
Jan 9 (Reuters) - NeuroScientific Biopharmaceuticals Ltd NSB.AX: REQUESTS HALT PENDING SPECIAL ACCESS PROGRAM RESULTS Further company coverage: NSB.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuroscientific Biopharmaceuticals
See all newsBrief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO
Australia's NeuroScientific Biopharmaceuticals soars on buying biotech co